Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Apr;219(4):325-31.
doi: 10.1097/00000658-199404000-00001.

Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer

Affiliations

Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer

J S Falconer et al. Ann Surg. 1994 Apr.

Abstract

Objective: To determine whether resting energy expenditure (REE) is increased in cachectic patients with pancreatic cancer and to define the relation of tumor necrosis factor (TNF) and interleukin-6 (IL-6) production to the acute-phase response and to REE.

Methods: Measurement of REE (indirect calorimetry) and assessment of body composition (bioelectrical impedance analysis) were done in 21 patients with unresectable pancreatic cancer and on 16 age-related controls. The systemic inflammatory response in peripheral blood of the cancer patients was assessed using the acute-phase protein, C-reactive protein, and the cytokines TNF and IL-6. Production of these cytokines by peripheral blood mononuclear cells in vitro was also measured.

Results: Patients with pancreatic cancer had an elevated REE when compared with controls (73.4 +/- 5.0 vs. 53.5 +/- 1.6 kcal/kg body cell mass; p < 0.003). Resting energy expenditure was significantly greater in cancer patients with an acute-phase response (C-reactive protein > 10 mg/L) than in those who did not have such a response (85.5 +/- 10.0 [n = 9] vs. 64.3 +/- 3.0 [n = 12] kcal/kg body cell mass; p < 0.04). Tumor necrosis factor was not detected in the serum of any of the cancer patients. Serum IL-6 was detected but levels were not significantly different among cancer patients with or without an acute-phase response. In contrast, spontaneous production of TNF and IL-6 by isolated peripheral blood mononuclear cells was significantly greater in cancer patients with an acute-phase response that in those without (TNF: 1231 +/- 244 vs. 210 +/- 54 pg/ml/10(5) cells; p < 0.001; IL-6: 11.5 +/- 1.7 vs. 3.6 +/- 1.4 ng/mL/10(5) cells; p < 0.003).

Conclusions: In pancreatic cancer at least a component of weight loss is due to increased REE. Furthermore, the presence of an acute-phase response identifies a group of patients who are markedly hypermetabolic. The serum concentration of TNF of IL-6 does not correlate with the presence of an acute-phase response, whereas rates of cytokine production by peripheral blood mononuclear cells are significantly greater in patients with such a response. This suggests that local rather than systemic cytokine production may be important in regulating the acute-phase response.

PubMed Disclaimer

Comment in

  • Hypermetabolism and advanced cancer.
    Mullen JL. Mullen JL. Ann Surg. 1994 Apr;219(4):323-4. doi: 10.1097/00000658-199403000-00014. Ann Surg. 1994. PMID: 8161257 Free PMC article. No abstract available.

Similar articles

Cited by

References

    1. Eur J Cancer. 1991;27(1):9-15 - PubMed
    1. Lancet. 1984 Jun 30;1(8392):1423-6 - PubMed
    1. Ann Surg. 1986 Mar;203(3):240-5 - PubMed
    1. Cell. 1987 Aug 14;50(4):555-63 - PubMed
    1. Clin Physiol. 1987 Aug;7(4):263-74 - PubMed

Publication types